Antibacterial effects of curcumin encapsulated in nanoparticles on clinical isolates of Pseudomonas aeruginosa through downregulation of efflux pumps
Curcumin as a flavonoid from the rhizome of Curcuma longa has antibacterial, antiviral and antifungal activity. Multidrug resistance in pathogenic bacteria is continuously increasing in hospitals. The aim of this study was to investigate the effect of curcumin encapsulated in micellar/polymersome nanoparticles as an efflux pump inhibitor (EPI) on the expression of mexX and oprM genes in curcumin-treated and -untreated isolates of Pseudomonas aeruginosa. Clinical isolates of Pseudomonas aeruginosa were treated with ciprofloxacin (sub-MICs) alone and/or in combination with curcumin-encapsulated in micellar/polymersome nanoparticles. The expression of mexX and oprM genes was quantitatively evaluated by qRT-PCR in curcumin-treated and -untreated bacteria after 24 h. Curcumin-encapsulated in nanoparticles (400 µg/mL) induced cell death up to 50% in ciprofloxacin-treated (1/2MIC) resistant isolates during 24 h, while the bacteria treated with ciprofloxacin (without curcumin) were not inhibited. Also, curcumin in different concentrations increased effect of ciprofloxacin (sub-MICs). Downregulation of mexX and oprM genes was observed in cells treated with curcumin and ciprofloxacin compared to cells treated with ciprofloxacin alone. It seems that curcumin can be used as complementary drug in ciprofloxacin-resistant isolates through downregulating genes involved in efflux pumps and trapping ciprofloxacin on bacterial cells and increasing the effects of drug.
KeywordsCiprofloxacin Curcumin MexX Micellar/polymersome nanoparticles Pseudomonas aeruginosa OprM
Hereby, we appreciate Dr. Farhood Najafi for synthesis of CMN. We also would like to thank Seyed Reza Garakoui for his cooperation.
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest.
- 2.Negi N, Prakash P, Gupta ML, Mohapatra TM (2014) Possible role of curcumin as an efflux pump inhibitor in multi drug resistant clinical isolates of Pseudomonas aeruginosa. J Clin Diagn Res 8::DC04–D7Google Scholar
- 4.Blanco P, Hernando-Amado S, Reales-Calderon JA, Corona F, Lira F, Alcalde-Rico M, Bernardini A, Sanchez MB, Martinez JL (2016) Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants. Microorganisms 4Google Scholar
- 5.Ballard E, Coote PJ (2016) Enhancement of antibiotic efficacy against multi-drug resistant Pseudomonas aeruginosa infections via combination with curcumin and 1-(1-naphthylmethyl)-piperazine. J Antimicrob Agents 2Google Scholar
- 9.Teow SY, Liew K, Ali SA, Khoo AS, Peh SC (2016) Antibacterial action of curcumin against Staphylococcus aureus: a brief review. J Trop Med 2016:2853045Google Scholar
- 10.Erfani-Moghadam V, Nomani A, Zamani M, Yazdani Y, Najafi F, Sadeghizadeh M (2014) A novel diblock of copolymer of (monomethoxy poly [ethylene glycol]-oleate) with a small hydrophobic fraction to make stable micelles/polymersomes for curcumin delivery to cancer cells. Int J Nanomed 9:5541–5554CrossRefGoogle Scholar
- 11.Meng B, Li J, Cao H (2013) Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. Curr Pharm Des 19:2101–2113Google Scholar
- 12.Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K (2014) A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int 2014:186864Google Scholar
- 13.Sasidharan NK, Sreekala SR, Jacob J, Nambisan B (2014) In vitro synergistic effect of curcumin in combination with third generation cephalosporins against bacteria associated with infectious diarrhea. Biomed Res Int 2014:561456Google Scholar
- 15.Cockerill F, Patel J, Alder J, Bradford P, Dudley M, Eliopoulos G (2013) Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement; M100-S23. CLSI, WayneGoogle Scholar
- 21.Tahmasebi Birgani M, Erfani-Moghadam V, Babaei E, Najafi F, Zamani M, Shariati M, Nazem S, Farhangi B, Motahari P, Sadeghizadeh M (2015) Dendrosomal nano-curcumin; the novel formulation to improve the anticancer properties of curcumin. Progr Biol Sci 5:143–158Google Scholar
- 23.Ungphaiboon SST, Singchangchai P, Sungkarak S, Rattanasuwan P, Itharat A (2005) Study on antioxidant and antimicrobial activities of turmeric clear liquid soap for wound treatment of HIV patients. Thai Herbs 27:569–578Google Scholar
- 25.Rahimi HR, Nedaeinia R, Shamloo AS, Nikdoust S, Oskuee RK (2016) Novel delivery system for natural products: nano-curcumin formulations. Avicenna J Phytomed 6:383–398Google Scholar
- 27.Esmatabadi MJD, Sarkandi M, Zadeh HM, Khaledi G, Montazeri M, Shekarabi HSZ, Hormoz YA, Asgari EA (2015) Comparative evaluation of curcumin and curcumin loaded- dendrosome nanoparticle effects on the viability of SW480 colon carcinoma and Huh7 hepatoma cells. Res J Pharmacogn 2:9–16Google Scholar
- 28.Tahmasebi Mirgani M, Isacchi B, Sadeghizadeh M, Marra F, Bilia AR, Mowla SJ, Najafi F, Babaei E (2014) Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells. Int J Nanomed 9:403–417Google Scholar
- 35.Syng-Ai C, Kumari AL, Khar A (2004) Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 3:1101–1108Google Scholar
- 36.Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C (2015) Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res 35:645–651Google Scholar